Fresenius SE & Co KGaA at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm David Adlington. I head up the research group for JPMorgan in London for Medical Devices and Services. It's my pleasure this morning to introduce Michael Sen from Fresenius SE, and then we'll follow up the presentation with some Q&A. Michael, thank you very much.
So good morning, everybody, and thank you, David. Thanks for having us. I think it's a wonderful opportunity to come together at the JPMorgan Healthcare Conference. We've been talking about that one that it is the industry gathering, a lot of stuff going also around the conferences, meeting periods. But I would also say there could not be any better time for this conference.
And that's why I'm delighted to say, we're committed to life, which is our brand claim. And even the title introducing a health care company even so it might sound very easy is exactly what we're talking about. It's about health care. We got everything in our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

